(Q44897606)

English

Non-invasive index for predicting significant liver fibrosis: comparison of diagnostic performances in patients with chronic hepatitis B and C.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Non-invasive index for predicting significant liver fibrosis: comparison of diagnostic performances in patients with chronic hepatitis B and C. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

chronic hepatitis B

1 reference

based on heuristic

inferred from title

7

object named as

Mong Cho

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Jae Youn Cheong

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Soon Ho Um

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Yeon Seok Seo

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Dong Joon Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Seong Gyu Hwang

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Youn Jae Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Jin Mo Yang

8

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Young Bae Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Young Nyun Park

10

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sung Won Cho

11

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

29 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

555-563

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Diagnosis, management, and treatment of hepatitis C: an update

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

A novel panel of blood markers to assess the degree of liver fibrosis

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Serum markers detect the presence of liver fibrosis: a cohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Meta-analyses of FibroTest diagnostic value in chronic liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

An appraisal of the histopathological assessment of liver fibrosis

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Sampling variability of liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1007%2FS10620-010-1305-3

21 January 2018

Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/20585981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathomorphologic comparison of hepatitis C virus-related and hepatitis B virus-related cirrhosis bearing hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20585981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of liver biopsy in chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/20585981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20585981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/20585981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest

1 reference

https://pubmed.ncbi.nlm.nih.gov/20585981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10620-010-1305-3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44897606&oldid=2206980096"